Cargando…
Etanercept (Enbrel(®)) alternative storage at ambient temperature
BACKGROUND: Biologic disease-modifying antirheumatic drugs, including tumor necrosis factor inhibitors such as etanercept (Enbrel(®)), have improved outcomes for patients with rheumatic and other inflammatory diseases, with sustained remission being the optimal goal for patients with rheumatoid arth...
Autores principales: | Shannon, Edel, Daffy, Joanne, Jones, Heather, Paulson, Andrea, Vicik, Steven M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531722/ https://www.ncbi.nlm.nih.gov/pubmed/28790869 http://dx.doi.org/10.2147/CPAA.S131832 |
Ejemplares similares
-
Nodular Vasculitis That Developed during Etanercept (Enbrel) Treatment in a Patient with Psoriasis
por: Park, Seung-Bae, et al.
Publicado: (2015) -
Comment on “New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept”
por: Hassett, Brian, et al.
Publicado: (2018) -
Addition Of A Sleeve To The Etanercept Autoinjector (Enbrel(®) MyClic(®)) Improves Ease Of Use In Patients With Rheumatoid Arthritis
por: Rekaya, Naceur, et al.
Publicado: (2019) -
A randomized phase l pharmacokinetic study comparing SB4 and etanercept reference product (Enbrel®) in healthy subjects
por: Lee, Yoon Jung, et al.
Publicado: (2016) -
Erratum to: Perceptions and Preferences of Two Etanercept Autoinjectors for Rheumatoid Arthritis: A New European Union-Approved Etanercept Biosimilar (Benepali(®)) Versus Etanercept (Enbrel(®)) - Findings from a Nurse Survey in Europe
por: Thakur, Kunal, et al.
Publicado: (2016)